900 likes | 1.2k Views
Pain Management: Practicing the Art. M. Rachel McDowell, RN, MSN, ACNP-BC Cancer Supportive Care Nurse Practitioner Vanderbilt-Ingram Cancer Center. Goals of presentation. Provide steps for developing treatment plan Approach to titration (upward and downward) Patient education
E N D
Pain Management: Practicing the Art M. Rachel McDowell, RN, MSN, ACNP-BC Cancer Supportive Care Nurse Practitioner Vanderbilt-Ingram Cancer Center
Goals of presentation • Provide steps for developing treatment plan • Approach to titration (upward and downward) • Patient education • Consent for treatment • Utilization of controlled substance databases • Urine drug screens use and interpretation
Benefits of pain control Earlier mobilization Shortened hospitalization Reduced cost Improved QOL Decrease in patient suffering
Pain Assessment • Location • Character • Achy • Sharp • Jabbing • Deep or Superficial • Burning, tingling, numbness • Duration: when did this begin? • Frequency: constant, intermittent, am, pm?
Lorne B. Yudcovitch, OD, MS, FAAO; College of Optometry, Pacific University; 2043 College Way; Forest Grove, OR 97116 “The Use of Anesthetics, Steroids, Non-Steroidals, and Central-Acting Analgesics in the Management of Ocular Pain” Retrieved from http://www.google.com/imgres?imgurl=http://pacificu.edu/optometry/ce/courses/22746/images/clip_image002.jpg&imgrefurl=http://www.pacificu.edu/optometry/ce/courses/22746/ocularpainpg1.cfm&h=274&w=564&sz=37&tbnid=BdvVnqYJnZHq3M:&tbnh=65&tbnw=134&prev=/images%3Fq%3DPain%2BAssessment%2Bscales&hl=en&usg=__TdhB-pWbp_ouIYHvwQ4FJ1dHzgw=&ei=BBR2S6T_IMGXtgeCnqSlCg&sa=X&oi=image_result&resnum=7&ct=image&ved=0CCEQ9QEwBg Intensity: Pain Scale
Treatment Plan • Goal of Therapy: • Decrease pain level • Pain is mostly controlled, most of the time • Increase level of function • Minimal side effects from regimen • Time frame – acute or chronic
Important Factors • Etiology of pain, prognosis • Stage of disease – how aggressive do you want to be? • What kind of pain or combo do they have? • What have they been tried on in the past? • How did it work for them, side effects, adverse events? • Age, performance status • History or current issue with drug misuse/abuse • What kind of insurance do they have or not? • How capable is the patient in understanding plan?
Treatment Options • Treat underlying cause • Non-pharmacological measures • Pharmacological measures • No single modality done in isolation will be effective for most patients with chronic noncancer pain (CNCP) (Ashburn, Staats, Lancet 1999)
Nonpharmacologic Options • Biofeedback • Relaxation therapy • Physical and occupational therapy • Cognitive/behavioral strategies • Guided imagery • Acupuncture • Transcutaneous electrical nerve stimulation • Positioning • Rest, activity • Massage • Heat and cold
Treatment for pain • Identify the cause of the pain • Primary treatment if indicated • Radiation • Surgery • Hyperbaric treatment • Interventions: Nerve Block, Kyphoplasty • Medications
Interventional Techniques • Interventional Therapies • Trigger points • Acupuncture • Nerve blocks • Facet denervation • Intrathecal pumps
Medications • Somatic/Nociceptive Pain • Opioids • NSAIDS • Neuropathic Pain • Anticonvulsants • Antidepressants - SNRIs • Bony Pain • NSAIDS • Steroids
Pharmacotherapeutics and the Nervous System Brain Descending Modulation Anticonvulsants Tricyclics, SNRI Opioids CNS Central Sensitization Anticonvulsants Opioids NMDS-Receptor Antagonists Tricyclic/SNRI Antidepressants PNS Spinal Cord Peripheral Sensitization Local Analgesics Topical Analgesics Anticonvulsants Antidepressants Opioids
Guidelines for opioids • WHO ladder combined with etiology-specific therapies for syndromes • pharmacologic and nonpharmacologic interventions • long-acting + short-acting opioids • adjuvant medications for neuropathic pain • NSAIDs and steroids can be helpful when there is an inflammatory component to pain
Step 3: Opioids for moderate-to-severe pain +/- non-opioid +/-adjuvant therapy Step 2: Opioids for mild- to-moderate pain +/- non-opioid +/- adjuvant therapy Step 1: Non-opioid +/- adjuvant therapy GOAL: Freedom From Pain STEP 3 Pain Persists STEP 2 Pain Persists STEP 1 WHO Guidelines for Cancer Pain (Adapted from Portenoy et al, 1997)
Opioid Selection • No perfect opioid • Pre-treat likely side effects • Must recognize individual responses to opioids may vary • Response and side effects • Hydrocodone vx. Oxycodone • Sequential trials of different opioids – alone or in combination – may be necessary to optimize therapy
Common Analgesics • Demerol • Morphine Sulfate IR • Percocet • Dilaudid • Lortab • Opana IR • Oxycodone • Tramadol • Butrans • Morphine Sulfate ER • OxyContin • Exalgo • Fentanyl patches • Opana ER • Methadone
Pure Opioid Agonists • Pure Opioid agonist • No ceiling effect for analgesia • Single-entity for moderate to severe pain • May be a role for combined opioids in certain subsets of patients
Current Regimen • Opioid Naïve: • Never been on opioids before • Only been on opioids for a short time period or intermittently • Opioid Tolerant • Taking pain medications on a regular basis • Dependent on amount of pain medication
Differences in older adult • Experience higher peak and longer duration of drug action • Age-related changes in drug distribution and elimination make more sensitive to sedation and respiratory distress • Pain perceived differently • Physiologic • Psychological • Cultural changes • Altered presentations • Aging does NOT increase Pain threshold • Older adults (esp frail and old-old) at risk for too little or too much
General Approach • Start pt on short acting • Titrate up for pain relief • Once stable convert to long acting • Add amount of short acting for 24 hours • Convert to long acting • Continue short acting for breakthrough pain • 10-15 % of 24 hour total narcotic
Advantages of Long-Acting Opioids • More predictable serum levels • More predictable pain relief • Avoids mini-withdrawals • Easier to use; improved compliance • Greater Patient satisfaction • Less reinforcement of drug-taking behavior
Titration of Opioids • Titrate to adequate pain control. Appropriate dose adjustments are critical to adequate pain control. Adjustments are indicated under the following circumstances • If the patient has been taking more than 4 rescue doses per day • If the patient rates pain as greater than 4/10 • If the patient complains the pain is inadequately controlled
Dose Titration • Based on two pieces of information: • Calculation of the 24-hour narcotic total (this should be averaged over several days unless the patient has had a marked increase in pain in the prior 24-hour period of time) • The stated average pain level (this should be averaged over several days unless the patient has had a marked increase in pain in the prior 24-hour period of time)
24-hour narcotic total: = 24o fixed dose + 24o rescue doses a patient is taking MSER 60 mg po bid with MSIR 15 mg po q1-2hrs prn for breakthrough. On history, he indicates that he is taking the sustained-release formulation as directed and 8 rescue doses in a 24-hour period of time.
The 24-hour narcotic total is: (60 mg x 2 doses) + (15 mg x 8 doses) = 120 mg + 120 mg = 240 mg.
Dose Titration Dose titration by a fixed percentage Moderate pain (5/6): increase 24 hour narcotic total by 25% Severe pain (7+): increase narcotic total by 50% Rescue dose: 10-15%of total dose offered Q 1-2 hours PRN Accommodate increase if pt frail, sick, or elderly
Case Study Pt reports 6/10 pain, therefore he requires a 25 % increase in medication. 2. Pt’s 24 hour narcotic total = ___ mgmorphine
Step 1: Increase dose by 25% 24 NT mg + (24 NT x .25) = New long acting dose
Step 2: Determine the new fixed dose New fixed dose / 2 doses per day = X mg bid
Step 3 Calculate the rescue dose 10% of NT mg = X mg New rescue order = MSIR X mg q2h prn
Old regimen MSER 60 mg bid MSIR 15 mg q 2 prn New regimen MSER 150 mg bid MSIR 30 mg q 2 prn
Case Study Pt reports 8/10 pain. What do you do?
Pt reports 8/10 pain, therefore he requires a 50 % increase in his medication. Pt’s 24 hour narcotic total = 240 mg morphine
Step 1: Increase dose by 50% 24 NT mg + (24 NT x .50) = 240 mg + ___ = ___ mg
Step 2: • Determine the new fixed dose • ? mg / 2 doses per day = ? mg
Step 3: Calculate the rescue dose 10% of new 24 NT = ___ mg New rescue order = MSIR ___ mg q2h prn
Old regimen MSER 60 mg bid MSIR 15 mg q 2 prn New regimen MSER 180 mg bid MSIR 30 mg q 2 prn
Fentanyl Doses based on Daily Oral Morphine Dosage Or The ratio is 2:1 2 mg oral morphine per DAY ~ 1 mcq fentanyl patch
Fentanyl Patch In pts currently on opioids, conversion factor for Morphine to Fentanyl is 2:1 Fentanyl patch is 2X more potent than morphine PO If the 24 hr narcotic total= 180 mg morphine Fentanyl dose= ___ mg (use nearest fentanyl patch size)
IV to PO conversion Now your patient is ready to go home but need to be converted to PO medication. Pt is on a morphine pain pump at a continuous infusion of 7.5 mg/hour and uses the bolus of 1 mg 6 times in the past 24 hours.
Case Study 7.5 mg/hr X 24 = 180 mgmorphine IV/24 IV Narcotic total = 186 mg IV PO Narcotic total = 558 Opioid naïve: IV is 6X more potent than PO (1:6) Currently on opioid: IV is 3X more potent than PO (1:3)
4. Rescue dose is 10% = 60 mgmorphine q 2 hours prn 5. Long acting dose = 280 mg morphine bid
Old regimen: 7.5 mg/hour CIV, with 1 mg q 10 minutes prn New Regimen: MSER 280 mg bid MSIR 60 mg q 2 prn
Case Study A patient with a pathologic fracture had satisfactory relief of pain with an IV dilaudid infusion of 3 mg per hour. You want to send her home on an equianalgesic dose of sustained release oral morphine (MS Contin or OraMorph SR given q12h, or Kadian q day). What is the correct dose?
Calculations 1. 3 mg/hr dilaudid = 72 mg IVdilaudid/24 hrs 2. Convert from dilaudid to morphine: 72 mg dilaudidIV X 5 = 360 mg IV morphine 3. Narcotic total = 360 mg IVmorphine/24 hours
3. Narcotic total = 360 mg IVmorphine/24 hours 4. Multiply IV by 3 to obtain PO dose 360 x 3 = 1080 mg morphine in 24 hours PO 5. Breakthrough dose = 10 % of 24 hour narcotic total MSIR 30 mg, 3 tabs po q 2 prn Dilaudid8 mg, 2 tab po q 2 prn
6. The q12h dose = 500 mg morphine SR PO q12h MS Contin100 mg, 5 tabs po BID MS Contin100 mg, 3 tabs po TID
Old regimen: 3 mg/hr dilaudidIV New regimen: MS Contin 100 mg, 5 tabs po BID MS Contin 100 mg, 3 tabs po TID Rescue dosing MSIR 30 mg, 3 tabs po q 2 prn or Dilaudid8 mg, 2 tabs po q 2 prn